FELDAN THERAPEUTICS
Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of the unique characteristics of the Shuttle.
FELDAN THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2007-01-01
Address:
Quebec, Quebec, Canada
Country:
Canada
Website Url:
http://www.feldan.com
Total Employee:
11+
Status:
Active
Contact:
+1.418.872.7277
Email Addresses:
[email protected]
Total Funding:
15.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics Font Awesome Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Medical Center of the Americas Foundation
Medical Center of the Americas Foundation develops a robust and targeted bioscience ecosystem.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Feldan Therapeutics
National Institutes of Health
National Institutes of Health investment in Grant - Feldan Therapeutics
Asahi Kasei Corporate Venture Capital
Asahi Kasei Corporate Venture Capital investment in Series A - Feldan Therapeutics
GC
GC investment in Series A - Feldan Therapeutics
Groupe Roski
Groupe Roski investment in Series A - Feldan Therapeutics
AQC Capital
AQC Capital investment in Series A - Feldan Therapeutics
Stonebridge Ventures
Stonebridge Ventures investment in Series A - Feldan Therapeutics
Anges Quebec
Anges Quebec investment in Seed Round - Feldan Therapeutics
FIER Succes
FIER Succes investment in Seed Round - Feldan Therapeutics
Official Site Inspections
http://www.feldan.com
- Host name: rosemont.whc.ca
- IP address: 173.209.33.163
- Location: Saint-Quentin Canada
- Latitude: 47.51
- Longitude: -67.4013
- Timezone: America/Moncton
- Postal: E8A
More informations about "Feldan Therapeutics"
Feldan Therapeutics - Crunchbase Company Profile
Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. โฆSee details»
Feldan Therapeutics - About
Feldan is a clinical-stage pharmaceutical company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Feldan is behind the design of a โฆSee details»
Feldan Therapeutics ว Feldan Thérapeutiques - LinkedIn
Feldan Therapeutics ว Feldan Thérapeutiques | 3,413 followers on LinkedIn. Feldan is a clinical-stage pharmaceutical company that specialized in the development of innovative treatments โฆSee details»
Feldan Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Feldan Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Feldan Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Feldan will also be working on advancing its pulmonary delivery program towards preclinical development and further leveraging its intracellular delivery technology to offer life-changing โฆSee details»
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC โฆ
Feb 18, 2025 Feldan is also advancing its pulmonary program, leveraging the Shuttle's unique ability to transport biomolecules into hard-to-deliver lung cells to address the unmet and โฆSee details»
Feldan Bio, Inc.
ABOUT FELDAN THERAPEUTICS Feldan, located in Québec City, Canada, is a biopharmaceutical company pioneering the development of treatments based on the โฆSee details»
Feldan Therapeutics - Funding, Financials, Valuation & Investors
Feldan Therapeutics is funded by 15 investors. Linearis Ventures and Genesys Capital are the most recent investors.See details»
Feldan - VentureRadar
Feldan is a biopharmaceutical company focused on the development of treatments based on the intracellular delivery of therapeutics. It has designed the Feldan Shuttle, a proprietary, peptide โฆSee details»
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC โฆ
Feb 18, 2025 Feldan is a clinical-stage pharmaceutical company specializing in the development of treatments based on the intracellular delivery of therapeutics. Its proprietary peptide-based โฆSee details»
Feldan Therapeutics - Craft
Feldan Therapeutics is a biotechnology company developing treatments based on an intracellular delivery technology platform, the Feldan Shuttle. It enables the delivery of active nucleases, โฆSee details»
Company: Feldan Therapeutics - CRISPR Medicine
Feldan Therapeutics is a biotech company specialising in the development of novel therapies using a proprietary peptide-based delivery technology called Feldan Shuttle. The Feldan โฆSee details»
FELDAN THERAPEUTICS COMPLETES A US$ 21 MILLION SERIES B โฆ
Sep 4, 2024 Feldan is also advancing its pulmonary delivery program towards clinical development and further leveraging its intracellular delivery technology to offer life-changing โฆSee details»
Feldan Therapeutics Announces Additional Investment in Series A
Nov 27, 2018 "Our organization is happy to take part in Feldan's growth and excited to work with its great team of multidisciplinary specialists." About Feldan Therapeutics:See details»
FELDAN ANNOUNCES THE APPOINTMENT OF ERIC CARTER, โฆ
Jan 22, 2025 Quebec City, Canada, January 22, 2025 โ Feldan Therapeutics (โFeldanโ), a clinical-stage pharmaceutical company specializing in the development of treatments based โฆSee details»
FELDAN THERAPEUTICS SECURES $16.5M SERIES B TO BRING โฆ
Feldan will also be working on advancing its pulmonary delivery program towards preclinical development and further leveraging its intracellular delivery technology to offer life-changing โฆSee details»
Feldan Therapeutics Raises $12.5 Millions in Series A ... - Newswire
QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions Series A financing round led by GC (parent โฆSee details»
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC โฆ
Feb 18, 2025 Feldan is also advancing its pulmonary program, leveraging the Shuttle's unique ability to transport biomolecules into hard-to-deliver lung cells to address the unmet and โฆSee details»
Anges Québec - Feldan secures investment of over $1.7 million to ...
Feldan is a biotechnology company that collaborates with researchers and companies involved in regenerative medicine to improve peopleโs lives. The company provides high quality clinical โฆSee details»
Feldan Therapeutics - Therapeutics Focus
Feldan Therapeutics is developing FLD-103, an efficient, non-surgical approach to treat BCC. This first-in-class non-invasive intralesional treatment selectively targets BCC cells by โฆSee details»